Wells Fargo & Co reissued their market perform rating on shares of RenaissanceRe (NYSE:RNR) in a research report sent to investors on Tuesday morning, The Fly reports. Wells Fargo & Co currently has a $125.00 price objective on the insurance provider’s stock, down from their previous price objective of $140.00.

Several other analysts have also issued reports on the stock. Buckingham Research initiated coverage on shares of RenaissanceRe in a research report on Monday, September 11th. They issued a buy rating and a $165.00 target price on the stock. Keefe, Bruyette & Woods restated a hold rating and set a $136.00 price target on shares of RenaissanceRe in a research report on Monday, October 16th. Zacks Investment Research lowered shares of RenaissanceRe from a hold rating to a sell rating in a research report on Tuesday, October 24th. Citigroup upgraded shares of RenaissanceRe from a neutral rating to a buy rating and boosted their price target for the stock from $151.00 to $157.00 in a research report on Thursday, November 2nd. Finally, Morgan Stanley lowered their price target on shares of RenaissanceRe from $144.00 to $142.00 and set an equal weight rating on the stock in a research report on Thursday, November 2nd. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the stock. The company currently has a consensus rating of Hold and an average target price of $146.50.

Shares of RenaissanceRe (RNR) traded up $1.74 during midday trading on Tuesday, hitting $120.51. 397,544 shares of the stock traded hands, compared to its average volume of 445,056. RenaissanceRe has a 1-year low of $116.50 and a 1-year high of $152.00. The firm has a market capitalization of $4,840.00, a price-to-earnings ratio of -27.08, a price-to-earnings-growth ratio of 1.34 and a beta of 0.67. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.25.

RenaissanceRe (NYSE:RNR) last announced its earnings results on Tuesday, October 31st. The insurance provider reported ($13.81) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($12.25) by ($1.56). RenaissanceRe had a negative net margin of 7.60% and a negative return on equity of 5.82%. The company had revenue of $483.22 million during the quarter, compared to analyst estimates of $300.46 million. During the same quarter last year, the business earned $2.09 EPS. The firm’s revenue for the quarter was up 70.0% compared to the same quarter last year. equities analysts expect that RenaissanceRe will post -8.78 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Friday, December 15th were given a dividend of $0.32 per share. The ex-dividend date was Thursday, December 14th. This represents a $1.28 dividend on an annualized basis and a yield of 1.06%. RenaissanceRe’s payout ratio is presently -28.76%.

RenaissanceRe declared that its board has authorized a share repurchase program on Friday, November 10th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the insurance provider to repurchase shares of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s management believes its stock is undervalued.

In other RenaissanceRe news, SVP Sean G. Brosnan sold 1,391 shares of RenaissanceRe stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $135.73, for a total transaction of $188,800.43. Following the transaction, the senior vice president now directly owns 8,405 shares of the company’s stock, valued at $1,140,810.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin Odonnell sold 5,000 shares of RenaissanceRe stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $131.65, for a total transaction of $658,250.00. Following the transaction, the chief executive officer now directly owns 190,707 shares in the company, valued at $25,106,576.55. The disclosure for this sale can be found here. Insiders have sold 11,391 shares of company stock worth $1,524,950 over the last 90 days. 1.80% of the stock is currently owned by company insiders.

A number of hedge funds have recently modified their holdings of the business. M&T Bank Corp raised its stake in RenaissanceRe by 0.9% during the second quarter. M&T Bank Corp now owns 8,215 shares of the insurance provider’s stock worth $1,142,000 after purchasing an additional 74 shares during the period. Oppenheimer Asset Management Inc. raised its stake in RenaissanceRe by 2.7% during the second quarter. Oppenheimer Asset Management Inc. now owns 2,807 shares of the insurance provider’s stock worth $390,000 after purchasing an additional 75 shares during the period. ETRADE Capital Management LLC raised its stake in RenaissanceRe by 5.2% during the second quarter. ETRADE Capital Management LLC now owns 1,637 shares of the insurance provider’s stock worth $228,000 after purchasing an additional 81 shares during the period. Mutual of America Capital Management LLC raised its stake in RenaissanceRe by 0.8% during the second quarter. Mutual of America Capital Management LLC now owns 32,614 shares of the insurance provider’s stock worth $4,535,000 after purchasing an additional 263 shares during the period. Finally, PNC Financial Services Group Inc. raised its stake in RenaissanceRe by 16.5% during the second quarter. PNC Financial Services Group Inc. now owns 2,352 shares of the insurance provider’s stock worth $327,000 after purchasing an additional 333 shares during the period. 93.33% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This news story was posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://theolympiareport.com/2018/01/12/renaissanceres-rnr-market-perform-rating-reaffirmed-at-wells-fargo-co.html.

RenaissanceRe Company Profile

RenaissanceRe Holdings Ltd. provides reinsurance and insurance coverages and related services to a range of customers. The Company’s products include property, casualty and specialty reinsurance and certain insurance products principally distributed through intermediaries. Its segments include Property; Casualty and Specialty, and Other category.

The Fly

Analyst Recommendations for RenaissanceRe (NYSE:RNR)

Receive News & Ratings for RenaissanceRe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenaissanceRe and related companies with Analyst Ratings Network's FREE daily email newsletter.